[{"Assets_0_Q2_USD":2617500.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-4009900.0,"NetIncomeLoss_2_Q2_USD":-7262300.0,"NetIncomeLoss_1_Q2_USD":-4997000.0,"StockholdersEquity_0_Q2_USD":-1671600.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]